Alex S. Kim

Mr. Kim is a serial entrepreneur with 24 years of experience in the biopharmaceutical industry. During his career, he has focused on serving shareholders and inventors to build enterprise value for high-technology startups, many of which have gone on to become successful publicly-traded entities. He has served in numerous functions at these organizations including; executive management, business development, product and technology licensing, strategic planning, fund raising, and M&A activity. Mr. Kim’s work, as an early risk-taker at venture-stage companies, has contributed directly to the success of such firms which include Theratech, Inc. (now Watson Pharma); VivoRx, Inc. (Abraxis Pharmaceutical Products); Expression Genetics, Inc.; MacroMed, Inc. (now BTG, PLC); and LSK BioPartners, Inc (LSKB). Mr. Kim received a graduate degree in international business from SangJi (Sophia) University in Tokyo, Japan.